Cycle Guidelines Common Cagrilintide + Retatrutide Cycle Approaches Approach Full staggered titration Duration 24-week ramp + open-ended maintenance Off Period Community: 16-24 weeks on, 4-8 weeks off Best For Primary weight-loss strategy with full pathway coverage Approach Reta-first, cag add-on Duration Stabilize reta at 8-12 mg, then add cag for 12+ weeks Off Period Cag can be cycled on its own Best For Users already on retatrutide who want more satiety Approach Short-cycle test Duration 8-12 weeks at sub-maximal doses Off Period 4 weeks off Best For Initial tolerability check Taper retatrutide at the end of a cycle rather than stopping suddenly
In the Phase 3 REDEFINE 1 trial, the most commonly reported adverse events included nausea, vomiting, diarrhoea, and constipation
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit
Clinical Protocols Professional treatments use longer needles (1.0mm to 1.5mm) for deeper penetration